NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers

Oncogene

Volumn 22, Issue 6, 2003, Pages 947-954

  Hesson, Luke ^a   Dallol, Ashraf ^a   Minna, John D ^b   Maher, Eamonn R ^a,c   Latif, Farida ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Methylation; NORE1; RASSF1A

Indexed keywords

DIACYLGLYCEROL; RAS PROTEIN;

ARTICLE; BINDING SITE; CANCER GENETICS; CARBOXY TERMINAL SEQUENCE; COLORECTAL TUMOR; CPG ISLAND; DNA METHYLATION; EXON; GENE EXPRESSION; GENE INACTIVATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; KIDNEY TUMOR; LUNG TUMOR; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SOMATIC MUTATION; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DNA METHYLATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0037434724     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206191     Document Type: Article

References (22)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER and Latif F. (2001). Oncogene, 20, 1509-1518.
2. Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER and Latif F. (2001). Oncogene, 20, 7573-7577.
3. Baylin S and Bestor TH. (2002). Cancer Cell, 1, 299-305.
4. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
5. Byun DS, Lee MG, Chae KS, Ryu BG and Chi SG. (2001). Cancer Res., 61, 7034-7038.
6. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ. (1998). Oncogene, 17, 1395-1413.
7. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. (2000). Nat. Genet., 25, 315-319.
8. Dammann R, Takahashi T and Pfeifer GP. (2001). Oncogene, 20, 3563-3567.
9. Downward J. (2001). Nature, 411, 759-762.
10. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman Mi, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G and Zabarovsky ER. (2001). Proc. Natl. Acad. Sci. USA, 98, 7504-7509.
11. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
12. Khokhlatchev A, Rabizadeh S, Xavier R, Nedcoidek M, Chen T, Zhang XF, Seed B and Avruch J. (2002). Curr. Biol., 12, 253-265.
13. Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG and Chi SG. (2001). Cancer Res., 61, 6688-6692.
14. Lerman MI and Minna JD. (2000). Cancer Res., 60, 6116-6133.
15. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ and Huang DP. (2001). Cancer Res., 61, 3877-3881.
16. Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zochabauer-Muller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP and Gazdar AF. (2002). Clin. Cancer Res., 8, 514-519.
17. Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F and Maher ER. (2001). Cancer Res., 61, 7277-7281.
18. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP and Avruch J. (2002). Oncogene, 21, 1381-1390.
19. Ponting CP and Benjamin DR. (1996). Trends Biochem. Sci., 21, 422-425.
20. Tommasi S, Dammann R, Jin SG, Zhang XF, Avruch J and Pfeifer GP. (2002). Oncogene, 21, 2713-2720.
21. Vavvas D, Li X, Avruch J, Zhang XF. (1998). J. Biol. Chem., 273, 5439-5442.
22. Vos MD, Ellis CA, Bell A, Birrer MJ and Clark GJ. (2000). J. Biol. Chem., 275, 35669-35672.